Editor-in-Chief: Siest, Gérard
Editorial Board Member: Chen, Bing / Devinsky, Ferdinand / Henney, Adriano / Hirata, Rosario D. C. / Ingelman-Sundberg, Magnus / Llerena, Adrián / Manolopoulos, Vangelis G. / Meyer, Urs A. / Patrinos, George / Schaik, Ron / Sadee, Wolfgang / Turpeinen, Miia / Maitland-van de Zee, Anke-Hilse / Zanger, Ulrich M. / Marc, Janja / Hubacek, Jaroslav A.
4 Issues per year
Volume 27 (2012)
Volume 26 (2011)
Volume 25 (2010)
Volume 22 (2007)
Volume 21 (2006)
Volume 20 (2004)
Volume 19 (2003)
Volume 18 (2001)
Volume 16 (2000)
Volume 17 (2000)
Volume 15 (1999)
Volume 14 (1998)
Volume 13 (1997)
Volume 12 (1995)
Volume 11 (1994)
Volume 10 (1992)
Volume 9 (1991)
Volume 8 (1990)
Volume 5 (1987)
Volume 4 (1982)
Most Downloaded Articles
- 6th Santorini Conference Biologie Prospective 2012
- The aryl hydrocarbon receptor system by Barouki, Robert/ Aggerbeck, Martine/ Aggerbeck, Lawrence and Coumoul, Xavier
- European Best Practice Guidelines for Quality Assurance, Provision and Use of Genome-based Information and Technologies: the 2012 Declaration of Rome by Brand, Angela and Lal, Jonathan A.
- Public Health Genomics and Personalized Healthcare: a pipeline from cell to society by Brand, Angela
- Herb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymes by Zhou, Xuelin/ Chan, Kelvin and Yeung, John H.K.
ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells
1Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil
2Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, SP, Brazil
Citation Information: Drug Metabolism and Drug Interactions. Volume 26, Issue 1, Pages 33–36, ISSN (Online) 2191-0162, ISSN (Print) 0792-5077, DOI: 10.1515/dmdi.2011.101, March 2011
- Published Online:
Background: Enterocytes play a crucial role in high-density lipoprotein (HDL) biogenesis. Statins and ezetimibe are potent lowering-cholesterol drugs, which can also influence HDL plasma concentrations. We hypothesized that these drugs could modulate the expression of intestinal ABCA1and ABCG1, two genes involved in HDL metabolism.
Methods: Caco-2 cells were used as a model of the human intestinal cells and were treated with statins (0.01–1 μmol/L) and/or ezetimibe (0.5–5.0 μmol/L) for 12 h or 24 h. Gene expression was examined using real-time PCR.
Results: ABCA1 level was more abundant than ABCG1 in Caco-2 cells. ABCA1 was downregulated after 12-h and 24-h treatment with atorvastatin (0.1 and 1.0 μmol/L) or simvastatin (0.01, 0.1 and 1 μmol/L) (p<0.05). In statin-treated cells, ABCG1 levels remained unaltered. Ezetimibe alone did not induce change of ABCA1 or ABCG1 mRNA levels (p>0.05) but 24-h ezetimibe (2.5 or 5.0 μmol/L) plus simvastatin (1 μmol/L) treatment decreased the transcription of ABCA1 and ABCG1 (p<0.05).
Conclusions: Our findings reveal that, at the concentrations studied, statins isolated or combined with ezetimibe, but not ezetimibe alone, downregulate ABCA1 mRNA expression in Caco-2 cells. Moreover, simvastatin combined with ezetimibe treatment also decrease the ABCG1 levels in these cells.